Clinical Trial Update: Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Streptococcus Salivarius K12 for prevention and treatment of oral mucositis in patients undergoing radiotherapy for head and nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oral Mucositis

Drugs mentioned

• Streptococcus Salivarius K12 (Streptococcus Salivarius K12)

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED